Phase 1 biotech developing selective therapies for inflammatory and autoimmune diseases.
Industry: Health Care
Latest Trade: $1.74 +0.02 (+1.2%)
First Day Return: +31.4%
Return from IPO: -89.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/29/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 9.5 |
Deal Size ($mm) | $152 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/20/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 9.5 |
Deal Size ($mm) | $152 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Jefferies |
Evercore ISI |
more |
Company Data | |
---|---|
Headquarters | Encinitas, CA, United States |
Founded | 2018 |
Employees at IPO | n/a |
Website www.ventyxbio.com |